↗
investz
Investing, A to Z
Markets
News
Research
Screener
Sectors
Learn
Watchlists
Portfolio
Books
Audio
☀
S&P 500 · SPY
759.97
▼ -3.99 (-0.52%)
DOW JONES · DIA
521.37
▼ -6.52 (-1.24%)
NASDAQ · QQQ
704.40
▼ -0.07 (-0.01%)
GOLD · GLD
$366.61
▼ -2.39 (-0.65%)
OIL (WTI) · USO
$169.53
▲ +7.02 (+4.32%)
BITCOIN
$80,765.01
▲ +256.76 (+0.32%)
--:--:--
NYSE · Live ET
ANAB (ANAB)
48.73
+0.63 (+1.31%)
USD · · delayed · updates about every minute
☆ Add to watchlist
Key statistics
Previous close
48.10
Day range
47.05 – 48.89
52-week low
20.18
52-week high
72.36
Volume
—
Type
—
52-WEEK RANGE POSITION
ANAB news
MarketBeat
AnaptysBio (NASDAQ:ANAB) Stock Price Up 5.4% - What's Next?
3d ago
Simply Wall Street
Jemperli FDA Approval Could Expand AnaptysBio Stock Royalty Potential
4d ago
Yahoo Finance
Lakefront Biotherapeutics (ENXTAM:LKFT) Stock Looks Undervalued Despite A 40% Five Year Fall
4d ago
GuruFocus
AnaptysBio (ANAB) Shares Drop 8% Amid Delaware Breach of Contrac
4d ago
Seeking Alpha
AnaptysBio quickly drops amid hearing on GSK/Tesaro contract breach
4d ago
Simply Wall Street
AnaptysBio (ANAB) On Jemperli Approval Is The Royalty Story Still A Bargain
5d ago
GuruFocus
AnaptysBio (ANAB) Shares Rise After GSK's FDA Label Expansion fo
5d ago
Quiver Quantitative
AnaptysBio Announces FDA Approval of GSK’s Jemperli for MSI-H/dMMR Locally Advanced Rectal Cancer Based on AZUR-1 Data
5d ago
Learn to invest
The Psychology of Money
Morgan Housel ·
Beginner
The Little Book of Common Sense Investing
John C. Bogle ·
Beginner
The Intelligent Investor
Benjamin Graham ·
Intermediate